LAS VEGAS, NV, April 23, 2007
– IMPAC Medical Systems, Inc., an Elekta company and a leading
provider of oncology information technology solutions, joined
the National Cancer Registrars Association’s (NCRA) Journal of
Registry Management (JRM) today to announce the recipients of
the annual IMPAC-JRM Best Paper Award. IMPAC and JRM, NCRA's
official publication, partnered on this annual award to
recognize authors published in the journal during the year 2006.
The awards will be presented to the authors during NCRA’s Annual
Education Conference, April 23-25, 2007, in Las Vegas, NV.
The 2006 Best Paper Award went to, “Time and Motion Study for
Collaborative Stage and AJCC TNM 6th Edition - Staging
Information Project (SIP),” published in the August 2006 issue
of JRM. Jeri Kostyra, CTR, Ingrid Friesen, HRT, Karen Starratt,
HRA(c), Jo-Anne Janzen, HRT, CTR, Les Mery, MSc, and Elaine
Hamlyn, CTR, CCHRA (A) co-authored this paper.
2006 Honorable Mention was awarded to “Introduction to the
National Program of Cancer Registries-Modeling Electronic
Reporting Project (NPCR-MERP),” also published in the August
2006 issue of JRM. Sandra F. Thames, Kenneth Gerlach, MPH, CTR,
Howard J. Martin, PhD, MS, MA, Timothy Carney, MPH, MBA, Lynne
T. Penberthy, MD, MPH, Michael Lanzilotta, and Steven Peace, BS,
CTR co-authored this paper.
“The Best Paper Award recognizes authors that publish the
highest quality papers on topics of special significance to
registry professionals,” stated Herman R. Menck, MBA, editor of
Journal of Registry Management. “The sustained interest of IMPAC
in promoting this professionalism is especially valuable. We are
proud of our ongoing partnership with IMPAC on this award and we
look forward to honoring the recipients at the NCRA conference.”
“This is the fifth consecutive year that NCRA has awarded the
IMPAC-JRM Best Paper award, and IMPAC is delighted to continue
award sponsorship into the future,” stated Donna Couillard-Getreuer,
RN, MSN, CTR, IMPAC’s Director of Product Marketing for Decision
Support. “We remain dedicated to JRM’s commitment to excellence
and acknowledgement of authors for exemplary work in the field
of cancer registry.”
********
For more information, please contact:
Lorna Murdock, Marketing Communications Manager
IMPAC Medical Systems, Inc.
Tel: +1 408 830 8937, e-mail:
lmurdock@impac.com
Award Program
Inquiries:
Donna Getreuer, RN, MSN, CTR
Director, Product Marketing, Decision Support
IMPAC Medical Systems, an Elekta Company
Tel: +1 408-830-8000, e-mail:
dgetreuer@impac.com
Investor Enquiries:
Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000, e-mail:
peter.ejemyr@elekta.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., an Elekta company, provides
healthcare information technology (IT) solutions that streamline
clinical and business operations across the spectrum of cancer
care. IMPAC’s open integration to multiple healthcare data and
imaging systems offers oncology-specific patient charting and
practice management, as well as best-of-breed systems for
anatomic pathology, clinical laboratory, and cancer registry.
With products that are used in association with diagnosis and
treatment environments through long-term follow-up, IMPAC
provides a comprehensive oncology management solution that helps
improve overall communication, process efficiency, and quality
of patient care. For more information about IMPAC products and
services, please call 888-GO-IMPAC or visit
www.impac.com.
About
Elekta
Elekta is an international medical-technology Group, providing
meaningful clinical solutions, comprehensive information systems
and services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for
non-invasive treatment of brain disorders and Elekta Synergy®
for image guided radiation therapy (IGRT). Following the
acquisition of IMPAC Medical Systems Inc. in April 2005, the
Elekta Group is the world’s largest supplier of oncology
software. Elekta’s systems and solutions are used at over 4,000
hospitals around the world to treat cancer and manage clinical
operations as well as to diagnose and treat brain disorders,
including tumors, vascular malformations and functional
disorders. With approx. 2,000 employees, Elekta’s corporate
headquarter is located in Stockholm, Sweden and the company is
listed on the Stockholm Stock Exchange under the ticker EKTAb.
For more information about Elekta, please visit
www.elekta.com. |
|
Lorna Murdock
Marketing Communications Manager
IMPAC Medical Systems, Inc.
408-830-8937
pr@impac.com
Link Disclaimer
|
